Adjuvanted H5N1 influenza vaccine enhances both cross-reactive memory B cell and strain-specific naive B cell responses in humans
Ali H. Ellebedy(Washington University in St. Louis), Rafi Ahmed(Emory University), Wafaa B. Alsoussi(Washington University in St. Louis), Raffael Nachbagauer(Moderna Therapeutics (United States)), Bali Pulendran(Palo Alto University), Nadine Rouphael(Emory University), Aaron J. Schmitz(Washington University in St. Louis), Mario Cortese(Emory University), Julianna Han(Scripps Research Institute), Arvind Rajabhathor(Icahn School of Medicine at Mount Sinai), Daniel Stadlbauer(Icahn School of Medicine at Mount Sinai), Rustom Antia(Emory University), Daved H. Fremont(Washington University in St. Louis), Mark J. Mulligan(New York University), Scott D. Boyd(Stanford University), Andrew B. Ward(Scripps Research Institute), Katherine Jackson(Garvan Institute of Medical Research), Florian Krammer(Semmelweis University), Cathy Chang(Emory Healthcare), Megan McCausland(Emory Healthcare), Veronika Chromikova(Icahn School of Medicine at Mount Sinai), Lilin Lai(Emory Healthcare), Ya-Nan Dai(Washington University in St. Louis), Carl W. Davis(Emory University), Mary Bower(Emory University), Cheyann Kazemian(Emory University), Chakravarthy Chennareddy(Emory University), Veronika I. Zarnitsyna(Emory University)
Cited by 89
Related Papers
Influenza
|Nature Reviews Disease Primers|2018|1.5k
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors
|Nature Communications|2019|948
Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
|Cell Host & Microbe|2021|851